Related Experiment Video

Updated: May 13, 2026

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle
09:40

Phosphorus-31 Magnetic Resonance Spectroscopy: A Tool for Measuring In Vivo Mitochondrial Oxidative Phosphorylation Capacity in Human Skeletal Muscle

Published on: January 19, 2017

Mitochondrial mutations in atherosclerosis: new solutions in research and possible clinical applications

Igor A Sobenin1, Dimitry A Chistiakov, Yuri V Bobryshev

  • 1Laboratory of Medical Genetics, Russian Cardiology Research and Production Complex, 15-a 3rd Cherepkovskaya Str., 121552 Moscow, Russia. sobenin@cardio.ru.

Current Pharmaceutical Design
|February 27, 2013
PubMed

Insights

Mitochondrial DNA (mtDNA) dysfunction is increasingly linked to atherosclerosis, a major cause of cardiovascular disease. Heteroplasmic mtDNA mutations may serve as a novel biomarker for atherosclerosis susceptibility.

Area of Science:

  • Cardiovascular Science
  • Mitochondrial Biology
  • Vascular Pathology

Background:

  • Cardiovascular diseases (CVDs) are leading causes of death globally, with atherosclerosis as a primary driver.
  • Atherosclerosis stems from endothelial dysfunction and involves complex genetic and environmental interactions.
  • Mitochondrial factors play a critical role in atherosclerosis pathogenesis, impacting oxidative stress, metabolism, and energy balance.

Purpose of the Study:

  • To review the contribution of mitochondria-related factors to arterial vascular pathology.
  • To explore the role of mitochondrial DNA (mtDNA) alterations in atherosclerosis development.
  • To assess the potential of heteroplasmic mtDNA mutations as biomarkers for atherosclerosis.

Main Methods:

  • Literature review focusing on mitochondrial function and atherosclerosis.
  • Analysis of studies investigating mitochondrial DNA (mtDNA) heteroplasmy in coronary atherosclerosis.
  • Critical evaluation of evidence linking mitochondrial dysfunction to atherogenic mechanisms.

Main Results:

  • Impaired mitochondrial function and mtDNA changes contribute to oxidative stress, metabolic dysfunction, and altered energy homeostasis in atherosclerosis.
  • Somatic mitochondrial DNA (mtDNA) heteroplasmy levels correlate with coronary atherosclerosis.
  • Heteroplasmic mtDNA mutations show promise as molecular biomarkers for atherosclerosis susceptibility.

Conclusions:

  • Mitochondria are integral to atherosclerosis pathogenesis.
  • Heteroplasmic mtDNA mutations represent a potential new biomarker for genetic susceptibility to atherosclerosis.
  • Further research is needed to fully elucidate the role of mitochondria in vascular pathology.

More Related Videos

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models08:48

Using Live Cell STED Imaging to Visualize Mitochondrial Inner Membrane Ultrastructure in Neuronal Cell Models

Published on: June 30, 2023

Related Concept Videos

Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Membranes01:45

Mitochondrial Membranes

A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...